UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q2 2021 | 2021-08-04 | Future report Set alerts | |
| Q1 2021 | 2021-05-06 | -0.41 | -0.41 |
| Q4 2020 | 2021-02-23 | -0.33 | -0.33 |
| Q3 2020 | 2020-11-05 | -0.33 | 0.00 |
| Q2 2020 | 2020-08-06 | -0.35 | -0.35 |
| Q1 2020 | 2020-05-07 | -0.39 | -0.39 |
| Q4 2019 | 2020-02-27 | -0.39 | -0.40 |
| Q3 2019 | 2019-11-07 | -0.37 | -0.37 |
| Q2 2019 | 2019-08-08 | -0.38 | -0.38 |
| Q1 2019 | 2019-05-09 | -0.40 | -0.40 |
| 2016-06-15 | Reiterated Rating | BTIG Research | Buy | $26.00 |
| 2016-05-16 | Reiterated Rating | Piper Jaffray | Overweight | $25.00 |
| 2016-05-16 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $25.00 |
| 2016-05-15 | Reiterated Rating | BTIG Research | Buy | $26.00 |
| 2016-04-11 | Reiterated Rating | BTIG Research | Buy | $26.00 |
| 2016-04-11 | Reiterated Rating | Piper Jaffray | Buy | |
| 2016-03-24 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $17.00 |
| 2016-01-29 | Reiterated Rating | William Blair | Buy | |
| 2016-01-08 | Initiated Coverage | William Blair | Outperform | |
| 2015-12-31 | Reiterated Rating | Piper Jaffray | Buy | $25.00 |
| 2015-12-16 | Initiated Coverage | Piper Jaffray | Overweight | $25.00 |
| 2015-11-20 | Reiterated Rating | BTIG Research | Buy | |
| 2015-10-26 | Reiterated Rating | BTIG Research | Buy | $28.00 |
| 2015-08-25 | Upgrade | BTIG Research | Neutral to Buy | $28.00 |
| 2015-08-16 | Reiterated Rating | BTIG Research | Hold | |
| 2015-07-20 | Initiated Coverage | BTIG Research | Neutral |
| 2016-06-15 | Reiterated Rating | BTIG Research | Buy | $26.00 |
| 2016-05-16 | Reiterated Rating | Piper Jaffray | Overweight | $25.00 |
| 2016-05-16 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $25.00 |
| 2016-05-15 | Reiterated Rating | BTIG Research | Buy | $26.00 |
| 2016-04-11 | Reiterated Rating | BTIG Research | Buy | $26.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AXDX 89 funds of 2199 total. Show all
| Fund name | Ticker shares |
|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 3.78M |
| BlackRock Inc. | 2.37M |
| AXA | 1.63M |
| Vanguard Group, Inc | 1.61M |
| GRIFFIN ASSET MANAGEMENT, INC. | 1.36M |
| CANNELL PETER B & CO INC | 1.10M |
| STATE STREET CORP | 0.80M |
| CREDIT SUISSE AG/ | 0.79M |
| BlackRock Fund Advisors | 0.68M |
| BlackRock Institutional Trust Company, N.A. | 0.65M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.53M |
| Nuveen Asset Management, LLC | 0.44M |
| NORTHERN TRUST CORP | 0.38M |
| Rafferty Asset Management, LLC | 0.33M |
| LINDEN ADVISORS LP | 0.30M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| PATIENCE JOHN | 9.36% (4171211) | AXDX / SRCL / |
| SCHULER JACK W | 3.43% (1530423) | AXDX / BIOL / GTXI / HNSN / MBLX / MDT / QDEL / SRCL / VRML / |
| DDX INC /CO/ | 2.48% (1106793) | AXDX / |
| ARNOLD A ALEXANDER III | 1.78% (793000) | AXDX / |
| Mehren Lawrence CEO | 1.71% (762381) | AXDX / |
| FEINBERG LARRY N | 1.39% (621011) | AXDX / BIOL / HNSN / VRML / |
| GEIMER THOMAS J CEO/CFO | 0.76% (337985) | AXDX / |
| WILHELM DAVID C | 0.72% (319725) | AXDX / |
| Howson David President | 0.68% (301200) | AXDX / |
| GERRETSON CHARLES E | 0.31% (140150) | AXDX / |
| Strobeck Matthew | 0.31% (138235) | AXDX / MBLX / QDEL / |
| REICHLING STEVEN CFO | 0.07% (30700) | AXDX / |
| Kucera John D. | 0.06% (28663) | AXDX / |
| TEN BRINK FRANK JM | 0.02% (9800) | AXDX / SRCL / |
UM